These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9354926)

  • 21. Karyometry in the early detection and chemoprevention of intraepithelial lesions.
    Ranger-Moore J; Alberts DS; Montironi R; Garcia F; Davis J; Frank D; Brewer M; Mariuzzi GM; Bartels HG; Bartels PH
    Eur J Cancer; 2005 Sep; 41(13):1875-88. PubMed ID: 16087328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digital image analysis of breast epithelial cells collected by random periareolar fine-needle aspirates (RPFNA) from women at high risk for breast cancer taking hormone replacement and the aromatase inhibitor, letrozole, for six months.
    Frank DH; Kimler BF; Fabian CJ; Ranger-Moore J; Yozwiak M; Bartels HG; Alberts DS; Bartels PH
    Breast Cancer Res Treat; 2009 Jun; 115(3):661-8. PubMed ID: 19125322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture.
    Lippman SM; Lee JJ
    Cancer Res; 2006 Mar; 66(6):2893-903. PubMed ID: 16540634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
    Meyskens FL; Gerner EW
    Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diet and cancer: the disconnect between epidemiology and randomized clinical trials.
    Meyskens FL; Szabo E
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1366-9. PubMed ID: 15941942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress in clinical chemoprevention.
    Kelloff GJ; Hawk ET; Karp JE; Crowell JA; Boone CW; Steele VE; Lubet RA; Sigman CC
    Semin Oncol; 1997 Apr; 24(2):241-52. PubMed ID: 9129692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer chemoprevention trials using the fine-needle aspiration model.
    Kimler BF; Fabian CJ; Wallace DD
    J Cell Biochem Suppl; 2000; 34():7-12. PubMed ID: 10762008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological relevance of adduct detection to the chemoprevention of cancer.
    Sharma RA; Farmer PB
    Clin Cancer Res; 2004 Aug; 10(15):4901-12. PubMed ID: 15297390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear cytometric changes in breast carcinogenesis.
    Mommers EC; Poulin N; Sangulin J; Meijer CJ; Baak JP; van Diest PJ
    J Pathol; 2001 Jan; 193(1):33-9. PubMed ID: 11169513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Point: Surrogate end point biomarkers are likely to be limited in their usefulness in the development of cancer chemoprevention agents against sporadic cancers.
    Armstrong WB; Taylor TH; Meyskens FL
    Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):589-92. PubMed ID: 12869395
    [No Abstract]   [Full Text] [Related]  

  • 32. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.
    Kelloff GJ; Lippman SM; Dannenberg AJ; Sigman CC; Pearce HL; Reid BJ; Szabo E; Jordan VC; Spitz MR; Mills GB; Papadimitrakopoulou VA; Lotan R; Aggarwal BB; Bresalier RS; Kim J; Arun B; Lu KH; Thomas ME; Rhodes HE; Brewer MA; Follen M; Shin DM; Parnes HL; Siegfried JM; Evans AA; Blot WJ; Chow WH; Blount PL; Maley CC; Wang KK; Lam S; Lee JJ; Dubinett SM; Engstrom PF; Meyskens FL; O'Shaughnessy J; Hawk ET; Levin B; Nelson WG; Hong WK;
    Clin Cancer Res; 2006 Jun; 12(12):3661-97. PubMed ID: 16778094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear texture: can it be used as a surrogate endpoint biomarker?
    Palcic B
    J Cell Biochem Suppl; 1994; 19():40-6. PubMed ID: 7823604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Properties of intraepithelial neoplasia relevant to cancer chemoprevention and to the development of surrogate end points for clinical trials.
    Boone CW; Bacus JW; Bacus JV; Steele VE; Kelloff GJ
    Proc Soc Exp Biol Med; 1997 Nov; 216(2):151-65. PubMed ID: 9349684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trials with retinoids for breast cancer chemoprevention.
    Zanardi S; Serrano D; Argusti A; Barile M; Puntoni M; Decensi A
    Endocr Relat Cancer; 2006 Mar; 13(1):51-68. PubMed ID: 16601279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single cell multiple biomarker analysis in archival breast fine-needle aspiration specimens: quantitative fluorescence image analysis of DNA content, p53, and G-actin as breast cancer biomarkers.
    Rao JY; Apple SK; Hemstreet GP; Jin Y; Nieberg RK
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1027-33. PubMed ID: 9829712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evidence-based approach to cancer prevention clinical trials.
    Greenwald P; McDonald SS; Anderson DE
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S43-7. PubMed ID: 12570334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intermediate effect markers for colorectal cancer.
    Baron JA
    IARC Sci Publ; 2001; 154():113-29. PubMed ID: 11220651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies for phase II cancer chemoprevention trials: cervix, endometrium, and ovary.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1995; 23():1-9. PubMed ID: 8747372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers for breast cancer.
    Beenken SW; Bland KI
    Minerva Chir; 2002 Aug; 57(4):437-48. PubMed ID: 12145573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.